Crystal structure of the synergistic antibiotic pair, lankamycin and lankacidin, in complex with the large ribosomal subunit

Novel pharmaceutical molecules against emerging resistant gram-positive cocci

(2012) Roberto Manfredi et al.   Brazilian Journal of Infectious Diseases

Prevalence of phenotypic resistance of Staphylococcus aureus isolates to macrolide, lincosamide, streptogramin B, ketolid and linezolid antibiotics in Turkey

(2012) Riza Adaleti et al.   Brazilian Journal of Infectious Diseases

Regulation of Lankamycin Biosynthesis inStreptomyces rocheiby Two SARP Genes,srrYandsrrZ

(2010) Toshihiro SUZUKI et al.   BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY

Activity of quinupristin/dalfopristin against extracellular and intracellular Staphylococcus aureus with various resistance phenotypes

(2010) Pierre Baudoux et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Designer drugs for discerning bugs

(2010) S. Douthwaite   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The structure of ribosome-lankacidin complex reveals ribosomal sites for synergistic antibiotics

(2010) T. Auerbach et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A systematic study of 50S ribosomal subunit purification enabling robust crystallization

(2009) Thomas J. McLellan et al.   ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY

Molecular Mechanism of Drug-Dependent Ribosome Stalling

(2008) Nora Vazquez-Laslop et al.   MOLECULAR CELL